Buy & Sell Moderna, Inc. (MRNA) – Moderna, Inc. Price Today
Aura AI Summary
Moderna (MRNA) trades at $53.05, up 0.4% on the day, showing resilience amid mixed signals. The stock exhibits a bullish technical trend with strong moving average support, though RSI levels suggest potential near-term overbought conditions. Fundamentally, the company faces challenges with declining revenue and negative profitability, but recent earnings beats indicate potential operational improvements. News highlights focus on international vaccine opportunities and upcoming clinical data presentations.
The outlook remains speculative with significant revenue dependency on COVID-19 vaccine sales. Investment opportunity hinges on pipeline success in flu and RSV vaccines, while risks include sustained losses, competitive pressure, and litigation uncertainties. Analyst consensus is cautious with a hold-heavy rating and a price target below current levels.
Key Stats
- $21.52BMarket Cap
- HealthSector
- -22.67%3M Drawdown
- $17.02BEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 76 daysTypical Hold Time
52W Low: $22.36
20 Nov 2025
52W High: $57.8
04 Mar 2026
Moderna, Inc. (MRNA) is currently valued at a market capitalization of $21.52B, with an enterprise value of $17.02B. Over the past 52 weeks, Moderna, Inc. has traded between a low of $22.36 and a high of $57.8, highlighting its annual price range. Over the past three months, Moderna, Inc. has recorded a drawdown of -22.67%, reflecting recent price volatility. On average, investors hold Moderna, Inc. for approximately 76 days, indicating typical investor behavior on the platform.
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Technical Indicators
|
|
|
Overall Summary
Bearish (10)Neutral (10)Bullish (7)
People also bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions